Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 17334514)

Published in Thromb Haemost on March 01, 2007

Authors

Zoltán Vokó1, Zsuzsanna Bereczky, Eva Katona, Róza Adány, László Muszbek

Author Affiliations

1: Department of Preventive Medicine, Faculty of Public Health, Medical & Health Science Centre, University of Debrecen, Kassai út 26/b, 4028 Debrecen, Hungary. z.voko@sph.dote.hu

Articles by these authors

Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90

Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev (2011) 1.56

Blood pressure distribution in a Hungarian adolescent population: comparison with normal values in the USA. J Hypertens (2003) 1.44

Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol (2008) 1.29

A comparative health survey of the inhabitants of Roma settlements in Hungary. Am J Public Health (2007) 1.16

Interaction of factor XIII subunits. Blood (2014) 1.12

[Health status of the roma population in Hungary]. Orv Hetil (2002) 1.11

Sustainable prevention of obesity through integrated strategies: The SPOTLIGHT project's conceptual framework and design. BMC Public Health (2012) 1.09

Could the high level of cirrhosis in central and eastern Europe be due partly to the quality of alcohol consumed? An exploratory investigation. Addiction (2005) 1.09

Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma. Mod Pathol (2009) 1.09

New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals. Thromb Res (2013) 1.07

IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. BMC Med Genet (2009) 1.06

Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations. Immunogenetics (2009) 1.05

Studying vulnerable populations: lessons from the Roma minority. Epidemiology (2007) 0.99

Factor XIII Deficiency. Semin Thromb Hemost (2009) 0.97

A preliminary evaluation of a health monitoring programme in Hungary. Eur J Public Health (2005) 0.96

Factor XIII, clot structure, thrombosis. Thromb Res (2011) 0.95

Determinants of mental well-being in medical students. Soc Psychiatry Psychiatr Epidemiol (2009) 0.94

Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population. Thromb Res (2007) 0.93

Importance of ambulatory blood pressure monitoring in adolescent hypertension. Kidney Blood Press Res (2011) 0.93

Association study of the IL18RAP locus in three European populations with coeliac disease. Hum Mol Genet (2008) 0.92

EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis. Int J Cancer (2007) 0.92

Dietary self-efficacy: determinant of compliance behaviours and biochemical outcomes in haemodialysis patients. Nephrol Dial Transplant (2003) 0.91

Polymorphisms of TNF-alpha and LT-alpha genes in multiple myeloma. Leuk Res (2008) 0.91

The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk. Int J Cancer (2007) 0.90

Possible role of factor XIII subunit A in Fcgamma and complement receptor-mediated phagocytosis. Cell Immunol (2004) 0.90

Fibrin stabilization (factor XIII), fibrin structure and thrombosis. Pathophysiol Haemost Thromb (2005) 0.89

Characterization of 9p21 copy number alterations in human melanoma by fluorescence in situ hybridization. Cancer Genet Cytogenet (2008) 0.89

Factor XIII-A is involved in the regulation of gene expression in alternatively activated human macrophages. Thromb Haemost (2010) 0.88

Chromosomal imbalances in laryngeal and hypopharyngeal cancers detected by comparative genomic hybridization. Cytometry A (2005) 0.88

Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas. Otol Neurotol (2009) 0.87

Chromosomal imbalances are associated with increased proliferation and might contribute to bone destruction in cholesteatoma. Otolaryngol Head Neck Surg (2008) 0.87

Clinical and laboratory examinations in the subgroups of chronic urticaria. Int Arch Allergy Immunol (2007) 0.87

Effects of menadione, hydrogen peroxide, and quercetin on apoptosis and delayed luminescence of human leukemia Jurkat T-cells. Cell Biochem Biophys (2010) 0.85

Severe coagulation factor V deficiency caused by 2 novel frameshift mutations: 2952delT in exon 13 and 5493insG in exon 16 of factor 5 gene. Blood (2002) 0.85

Protein C and protein S deficiencies: similarities and differences between two brothers playing in the same game. Clin Chem Lab Med (2010) 0.85

Assessment of target-organ damage in adolescent white-coat and sustained hypertensives. J Hypertens (2010) 0.84

Three novel mutations in the glycoprotein IIb gene in a patient with type II Glanzmann thrombasthenia. Haematologica (2007) 0.84

Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency. Hum Mutat (2004) 0.84

Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency. Blood (2008) 0.84

Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study. Thromb Res (2011) 0.84

Environmental survey of segregated habitats of Roma in Hungary: a way to be empowering and reliable in minority research. Eur J Public Health (2009) 0.84

Antithrombin deficiency and its laboratory diagnosis. Clin Chem Lab Med (2010) 0.83

Thrombomodulin-dependent effect of factor VLeiden mutation on factor XIII activation. Thromb Res (2011) 0.83

Trombophilic screening for nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol (2005) 0.83

Factor XIII and inflammatory cells. Thromb Res (2012) 0.82

Factor XIII and atherothrombotic diseases. Semin Thromb Hemost (2010) 0.82

Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot. Thromb Haemost (2007) 0.81

[Survey of the state of health and health behavior among medical students in Hungary]. Orv Hetil (2008) 0.81

Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A. Thromb Haemost (2006) 0.81

Platelets but not monocytes contribute to the plasma levels of factor XIII subunit A in patients undergoing autologous peripheral blood stem cell transplantation. Blood Coagul Fibrinolysis (2004) 0.81

Elevated factor XIII level and the risk of peripheral artery disease. Haematologica (2008) 0.81

Prevalence rate of diabetes mellitus and impaired fasting glycemia in Hungary: cross-sectional study on nationally representative sample of people aged 20-69 years. Croat Med J (2010) 0.81

Acquired haemophilia: an often overlooked cause of bleeding - experience from a Hungarian tertiary care centre. Blood Coagul Fibrinolysis (2012) 0.81

Health impact assessment and evaluation of a Roma housing project in Hungary. Health Place (2010) 0.81

High-throughput scintillation proximity assay for transglutaminase activity measurement. Anal Biochem (2005) 0.80

Hyperventilation-induced cerebrovascular reactivity among hypertensive and healthy adolescents. Kidney Blood Press Res (2006) 0.80

Factor XIII and venous thromboembolism. Semin Thromb Hemost (2011) 0.80

Competitive enzyme-linked immonosorbent assay for N epsilon gamma-glutamyl lysine. Anal Biochem (2002) 0.80

Combined effect of ADH1B RS1229984, RS2066702 and ADH1C RS1693482/ RS698 alleles on alcoholism and chronic liver diseases. Dis Markers (2011) 0.80

Elevated factor XIII level and the risk of myocardial infarction in women. Haematologica (2007) 0.80

Validation of reference genes for the determination of platelet transcript level in healthy individuals and in patients with the history of myocardial infarction. Int J Mol Sci (2013) 0.80

Rapid detection of the factor XIII Val34Leu (163 G-->T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis. Clin Chem Lab Med (2004) 0.79

Binding of plasma factor XIII to thrombin-receptor activated human platelets. Thromb Haemost (2009) 0.79

Insertion/deletion polymorphism of angiotensin-1 converting enzyme is associated with metabolic syndrome in Hungarian adults. J Renin Angiotensin Aldosterone Syst (2011) 0.79

Factor XIII subunits in human tears; their highly elevated levels following penetrating keratoplasty. Clin Chim Acta (2010) 0.79

GJB2 mutations in patients with non-syndromic hearing loss from Northeastern Hungary. Hum Mutat (2004) 0.79

Measurement of factor XIII activity in plasma. Clin Chem Lab Med (2012) 0.79

Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease. Thromb Res (2007) 0.79

Mental health and behaviour of students of public health and their correlation with social support: a cross-sectional study. BMC Public Health (2011) 0.79

Gender-related differences in adolescent hypertension and in target organ effects. J Womens Health (Larchmt) (2010) 0.79

Extra copies of c-myc are more pronounced in nodular melanomas than in superficial spreading melanomas as revealed by fluorescence in situ hybridisation. Cytometry B Clin Cytom (2004) 0.79

Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization. Melanoma Res (2012) 0.78

Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of α2-plasmin inhibitor to fibrin and its consequences on fibrinolysis. Thromb Res (2012) 0.78

[Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation]. Orv Hetil (2002) 0.78

Rapid genotyping of paraoxonase 55 and 192 mutations by melting point analysis using real time PCR technology. Clin Chim Acta (2003) 0.78

The composition of surrogate and illegal alcohol products in Estonia. Alcohol Alcohol (2006) 0.78

[Epidemiological data of 15-18 year adolescents and the prevalence of hypertension in Debrecen. The Debrecen Hypertension Study]. Orv Hetil (2005) 0.78